Skip to main navigation Skip to search Skip to main content

SonALAsense Forges Ahead with First Patient Dosing for Devastating Childhood Brain Cancer

Press/Media: Research

PeriodSep 12 2022 → Sep 13 2022

Media coverage

10

Media coverage